Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

References

• KappelmanMDRifas-ShimanSLKleinmanKThe prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United StatesClin Gastroenterol Hepatol20075121424142917904915
   PubMed Web of Science ®Google Scholar
• BurischJJessTMartinatoMLakatosPLECCO-EpiComThe burden of inflammatory bowel disease in EuropeJ Crohns Colitis20137432233723395397
   PubMed Web of Science ®Google Scholar
• SartorRBMechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitisNat Clin Pract Gastroenterol Hepatol20063739040716819502
   PubMedGoogle Scholar
• SartorRBMicrobial influences in inflammatory bowel diseasesGastroenterology2008134257759418242222
   PubMed Web of Science ®Google Scholar
• EckburgPBBikEMBernsteinCNDiversity of the human intestinal microbial floraScience200530857281635163815831718
   PubMed Web of Science ®Google Scholar
• ZoetendalEGvon WrightAVilpponen-SalmelaTBen-AmorKAkkermansADde VosWMMucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from fecesAppl Environ Microbiol20026873401340712089021
   PubMed Web of Science ®Google Scholar
• SellonRKTonkonogySSchultzMResident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient miceInfect Immun19986611522452319784526
   PubMed Web of Science ®Google Scholar
• NagalingamNALynchSVRole of the microbiota in inflammatory bowel diseasesInflamm Bowel Dis201218596898421936031
   PubMed Web of Science ®Google Scholar
• FrankDNSt AmandALFeldmanRABoedekerECHarpazNPaceNRMolecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProc Natl Acad Sci U S A200710434137801378517699621
   PubMed Web of Science ®Google Scholar
• RiouxKPMadsenKLFedorakRNThe role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebioticsGastroenterol Clin North Am2005343465482 ix16084308
   PubMed Web of Science ®Google Scholar
• VanderpoolCYanFPolkDBMechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseasesInflamm Bowel Dis200814111585159618623173
   PubMed Web of Science ®Google Scholar
• DammanCJMillerSISurawiczCMZismanTLMicrobiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?Am J Gastroenterol2012107101452145923034604
   PubMed Web of Science ®Google Scholar
• MeagherAPFaroukRDozoisRRKellyKAPembertonJHJ ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patientsBr J Surg19988568008039667712
   PubMed Web of Science ®Google Scholar
• ScaldaferriFGerardiVLopetusoLRGut microbial flora, prebiotics, and probiotics in IBD: their current usage and utilityBiomed Res Int2013201343526823991417
   PubMed Web of Science ®Google Scholar
• VeerappanGRBetteridgeJYoungPEProbiotics for the treatment of inflammatory bowel diseaseCurr Gastroenterol Rep201214432433322581276
   PubMedGoogle Scholar
• FedorakRDemeriaDProbiotic bacteria in the prevention and the treatment of inflammatory bowel diseaseGastroenterol Clin North Am201241482184223101689
   PubMed Web of Science ®Google Scholar
• JonkersDPendersJMascleeAPierikMProbiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patientsDrugs201272680382322512365
   PubMed Web of Science ®Google Scholar
• PleinKHotzJTherapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn’s disease with special respect to chronic diarrhea – a pilot studyZ Gastroenterol19933121291348465554
   PubMed Web of Science ®Google Scholar
• MalchowHACrohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease?J Clin Gastroenterol19972546536589451682
   PubMed Web of Science ®Google Scholar
• GuslandiMMezziGSorghiMTestoniPASaccharomyces boulardii in maintenance treatment of Crohn’s diseaseDig Dis Sci20004571462146410961730
   PubMed Web of Science ®Google Scholar
• PranteraCScribanoMLFalascoGAndreoliALuziCIneffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GGGut200251340540912171964
   PubMed Web of Science ®Google Scholar
• SchultzMTimmerAHerfarthHHSartorRBVanderhoofJARathHCLactobacillus GG in inducing and maintaining remission of Crohn’s diseaseBMC Gastroenterol20044515113451
   PubMed Web of Science ®Google Scholar
• BousvarosAGuandaliniSBaldassanoRNA randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s diseaseInflamm Bowel Dis200511983383916116318
   PubMed Web of Science ®Google Scholar
• MarteauPLémannMSeksikPIneffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trialGut200655684284716377775
   PubMed Web of Science ®Google Scholar
• Van GossumADewitOLouisEMulticenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after ileo-caecal resectionInflamm Bowel Dis200713213514217206696
   PubMed Web of Science ®Google Scholar
• ChermeshITamirAReshefRFailure of Synbiotic 2000 to prevent postoperative recurrence of Crohn’s diseaseDig Dis Sci200752238538917211699
   PubMed Web of Science ®Google Scholar
• Garcia VilelaEDe Lourdes De Abreu FerrariMOswaldo Da Gama TorresHInfluence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn’s disease in remissionScand J Gastroenterol200843784284818584523
   PubMed Web of Science ®Google Scholar
• SteedHMacfarlaneGTBlackettKLClinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn’s diseaseAliment Pharmacol Ther201032787288320735782
   PubMed Web of Science ®Google Scholar
• BenjaminJLHedinCRKoutsoumpasARandomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s diseaseGut201160792392921262918
   PubMed Web of Science ®Google Scholar
• HaferAKrämerSDunckerSKrügerMMannsMPBischoffSCEffect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot studyBMC Gastroenterol200773617784949
   PubMed Web of Science ®Google Scholar
• BourreilleACadiotGLe DreauGFLORABEST Study GroupSaccharomyces boulardii does not prevent relapse of Crohn’s diseaseClin Gastroenterol Hepatol201311898298723466709
   PubMed Web of Science ®Google Scholar
• BestWRBecktelJMSingletonJWKernFJrDevelopment of a Crohn’s disease activity index. National Cooperative Crohn’s Disease StudyGastroenterology19767034394441248701
   PubMed Web of Science ®Google Scholar
• HyamsJSFerryGDMandelFSDevelopment and validation of a pediatric Crohn’s disease activity indexJ Pediatr Gastroenterol Nutr19911244394471678008
   PubMed Web of Science ®Google Scholar
• GoebellHEuropean cooperative Crohn’s disease study (ECCDS): Evaluation of different activity indices and development of a new severity-activity index (SAI)Inflamm Bowel Dis19881988253258
   Google Scholar
• RutgeertsPGeboesKVantrappenGBeylsJKerremansRHieleMPredictability of the postoperative course of Crohn’s diseaseGastroenterology19909949569632394349
   PubMed Web of Science ®Google Scholar
• TursiABrandimarteGGiorgettiGMFortiGModeoMEGigliobiancoALow-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitisMed Sci Monit20041011PI126PI13115507864
   PubMed Web of Science ®Google Scholar
• KatoKMizunoSUmesakiYRandomized placebo- controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitisAliment Pharmacol Ther200420101133114115569116
   PubMed Web of Science ®Google Scholar
• FurrieEMacfarlaneSKennedyASynbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trialGut200554224224915647189
   PubMed Web of Science ®Google Scholar
• SoodAMidhaVMakhariaGKThe probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitisClin Gastroenterol Hepatol2009711120212091209.e1.19631292
   PubMed Web of Science ®Google Scholar
• TursiABrandimarteGPapaATreatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled studyAm J Gastroenterol2010105102218222720517305
   PubMed Web of Science ®Google Scholar
• NgSCPlamondonSKammMAImmunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitisInflamm Bowel Dis20101681286129820155842
   PubMed Web of Science ®Google Scholar
• MatthesHKrummenerlTGienschMWolffCSchulzeJClinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)BMC Complement Altern Med2010101320398311
   PubMed Web of Science ®Google Scholar
• LiGZengSLiaoWLvNThe effect of bifid triple viable on immune function of patients with ulcerative colitisGastroenterol Res Pract2012201240475222927836
   PubMed Web of Science ®Google Scholar
• ChapmanTMPloskerGLFiggittDPVSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseasesDrugs200666101371138716903771
   PubMed Web of Science ®Google Scholar
• RizzelloFGionchettiPVenturiAAmadiniCRomagnoliRCampieriMReview article: monitoring activity in ulcerative colitisAliment Pharmacol Ther200216Suppl 43612047252
   PubMed Web of Science ®Google Scholar
• LichtigerSPresentDHKornbluthACyclosporine in severe ulcerative colitis refractory to steroid therapyN Engl J Med199433026184118458196726
   PubMed Web of Science ®Google Scholar
• HarigJMSoergelKHKomorowskiRAWoodCMTreatment of diversion colitis with short-chain-fatty acid irrigationN Engl J Med1989320123282909876
   PubMed Web of Science ®Google Scholar
• SchroederKWTremaineWJIlstrupDMCoated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized studyNEJM198731726162516293317057
   PubMed Web of Science ®Google Scholar
• KruisWSchützEFricPFixaBJudmaierGStolteMDouble-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitisAliment Pharmacol Ther19971158538589354192
   PubMed Web of Science ®Google Scholar
• RembackenBJSnellingAMHawkeyPMChalmersDMAxonATNon-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trialLancet1999354917963563910466665
   PubMed Web of Science ®Google Scholar
• IshikawaHAkedoIUmesakiYTanakaRImaokaAOtaniTRandomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitisJ Am Coll Nutr2003221566312569115
   PubMed Web of Science ®Google Scholar
• KruisWFricPPokrotnieksJMaintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut200453111617162315479682
   PubMed Web of Science ®Google Scholar
• CuiHHChenCLWangJDEffects of probiotic on intestinal mucosa of patients with ulcerative colitisWorld J Gastroenterol200410101521152515133865
   PubMed Web of Science ®Google Scholar
• ZoccoMAdal VermeLZCremoniniFEfficacy of Lactobacillus GG in maintaining remission of ulcerative colitisAliment Pharmacol Ther200623111567157416696804
   PubMed Web of Science ®Google Scholar
• FujimoriSGudisKMitsuiKA randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitisNutrition200925552052519201576
   PubMed Web of Science ®Google Scholar
• MieleEPascarellaFGiannettiEQuagliettaLBaldassanoRNStaianoAEffect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitisAm J Gastroenterol2009104243744319174792
   PubMed Web of Science ®Google Scholar
• WildtSNordgaardIHansenUBrockmannERumessenJJA randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitisJ Crohns Colitis20115211512121453880
   PubMed Web of Science ®Google Scholar
• HegazySKEl-BedewyMMEffect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitisWorld J Gastroenterol201016334145415120806430
   PubMed Web of Science ®Google Scholar
• IshikawaHMatsumotoSOhashiYBeneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled studyDigestion201184212813321525768
   PubMed Web of Science ®Google Scholar
• OlivaSDi NardoGFerrariFRandomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitisAliment Pharmacol Ther201235332733422150569
   PubMed Web of Science ®Google Scholar
• GuyattGMitchellAIrvineEJA new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology19899638048102644154
   PubMed Web of Science ®Google Scholar
• MattsSGThe value of rectal biopsy in the diagnosis of ulcerative colitisQ J Med19613039340714471445
   PubMedGoogle Scholar
• GionchettiPRizzelloFVenturiAOral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trialGastroenterology2000119230530910930365
   PubMed Web of Science ®Google Scholar
• KuismaJMentulaSJarvinenHKahriASaxelinMFarkkilaMEffect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial floraAliment Pharmacol Ther200317450951512622759
   PubMed Web of Science ®Google Scholar
• GionchettiPRizzelloFHelwigUProphylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trialGastroenterology200312451202120912730861
   PubMed Web of Science ®Google Scholar
• MimuraTRizzelloFHelwigUOnce daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisGut200453110811414684584
   PubMed Web of Science ®Google Scholar
• PronioAMontesaniCButteroniCProbiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cellsInflamm Bowel Dis200814566266818240282
   PubMed Web of Science ®Google Scholar
• CalabreseCFabbriAGionchettiPControlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitisAliment Pharmacol Ther200725111311131617509099
   PubMed Web of Science ®Google Scholar
• RahimiRNikfarSRahimiFA meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s diseaseDig Dis Sci20085392524253118270836
   PubMed Web of Science ®Google Scholar
• DohertyGABennettGCCheifetzASMossACMeta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s diseaseAliment Pharmacol Ther201031880280920055785
   PubMed Web of Science ®Google Scholar
• ShenJZuoZXMaoAPEffect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: meta-analysis of randomized controlled trialsInflamm Bowel Dis2014201213524280877
   PubMed Web of Science ®Google Scholar
• MallonPMcKayDKirkSGardinerKProbiotics for induction of remission in ulcerative colitisCochrane Database Syst Rev20074CD00557317943867
   PubMed Web of Science ®Google Scholar
• NaidooKGordonMFagbemiAOThomasAGAkobengAKProbiotics for maintenance of remission in ulcerative colitisCochrane Database Syst Rev201112CD00744322161412
   PubMed Web of Science ®Google Scholar
• ElahiBNikfarSDerakhshaniSVafaieMAbdollahiMOn the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trialsDig Dis Sci20085351278128417940902
   PubMed Web of Science ®Google Scholar
• EisemanBSilenWBascomGSKauvarAJFecal enema as an adjunct in the treatment of pseudomembranous enterocolitisSurgery195844585485913592638
   PubMed Web of Science ®Google Scholar
• BorodyTJCampbellJFecal microbiota transplantation: techniques, applications, and issuesGastroenterol Clin North Am201241478180323101687
   PubMed Web of Science ®Google Scholar
• GrehanMJBorodyTJLeisSMCampbellJMitchellHWettsteinADurable alteration of the colonic microbiota by the administration of donor fecal floraJ Clin Gastroenterol201044855156120716985
   PubMed Web of Science ®Google Scholar
• BorodyTJWarrenEFLeisSSuraceRAshmanOTreatment of ulcerative colitis using fecal bacteriotherapyJ Clin Gastroenterol2003371424712811208
   PubMed Web of Science ®Google Scholar
• AndersonJLEdneyRJWhelanKSystematic review: faecal micro-biota transplantation in the management of inflammatory bowel diseaseAliment Pharmacol Ther201236650351622827693
   PubMed Web of Science ®Google Scholar
• KundeSPhamABonczykSSafety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitisJ Pediatr Gastroenterol Nutr201356659760123542823
   PubMed Web of Science ®Google Scholar
• TurnerDOtleyARMackDDevelopment, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter studyGastroenterology2007133242343217681163
   PubMed Web of Science ®Google Scholar